Newsroom

SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Calix, Inc. (NYSE: CALX) launched enhancements to Calix Agent Workforce™ Cloud that help service providers improve campaign measurement, simplify subscriber support, and strengthen network intelligence. Embedded across Calix Engagement Cloud, Operations Cloud, and Service Cloud on the AI-native Calix One™ platform, these new capabilities further enable Calix customers to transform operations and accelerate experiences to compete and win in any market. T...

OVERLAND PARK, Kan.--(BUSINESS WIRE)--The Kansas City Auto Show moves to Overland Park Convention Center June 4-7 -- new dates, new location, 25+ brands, test drives and free parking....

PORT OF SPAIN, Trinidad and Tobago--(BUSINESS WIRE)--Update on Planned Redevelopment...

NEW YORK--(BUSINESS WIRE)--KBRA assigns ratings of ‘BBB (sf)’ to the Series 2026-GT1 Term Notes from PNMAC GMSR ISSUER TRUST, PennyMac Loan Services, LLC’s (PLS) master trust issuer of notes backed by participation certificates evidencing participation interest in mortgage servicing rights (MSR) on loans underlying Ginnie Mae guaranteed mortgage backed securities. KBRA’s rating on the notes is primarily dependent upon the rating of Private National Mortgage Acceptance Company, LLC (PNMAC), as r...

LONDEN--(BUSINESS WIRE)--Duco heeft vandaag het eerste agentgebaseerde operationele platform voor de financiële sector gelanceerd. Het platform is gebouwd op de engine die maandelijks al 20 miljard transacties verwerkt voor meer dan 200 klanten, waaronder zeven van de twintig grootste banken en tien van de twintig grootste vermogensbeheerders. Het biedt bedrijven alles wat ze nodig hebben om hun operationele activiteiten na de transactie veilig en op grote schaal uit te voeren, in samenwerking...

SAN FRANCISCO--(BUSINESS WIRE)--Vanta, the leading Agentic Trust Platform, today announced it has been named a Leader in The Forrester Wave™: Governance, Risk, and Compliance Platforms, Q2 2026, upon its first-ever inclusion in the evaluation. Vanta believes the recognition affirms its leadership in shaping a GRC category that is automation-first, AI-native, and continuous. Forrester's market analysis describes a category in transition, framed as “Automation Revitalizes GRC's Role As Outcome Or...

JASPER, Ala.--(BUSINESS WIRE)--Pinnacle Bancshares, Inc. (OTCID: PCLB) today announced that its Board of Directors has approved a quarterly cash dividend of $0.27 per share. The dividend is payable June 22, 2026 to stockholders of record on June 8, 2026. The quarterly amount is equivalent to an annualized rate of $1.08 per share....

LEBANON, Ohio--(BUSINESS WIRE)--LCNB Corp. (Nasdaq: LCNB, the “Company”) today announced that its wholly owned subsidiary, LCNB National Bank (the “Bank”), added two experienced banking professionals to its Columbus team, further strengthening the Bank’s presence and commitment to the region. Jeff Beyke has joined the Bank as a market leader, senior vice president, serving the Columbus market. He will work alongside William (Will) Newell, who recently joined LCNB as branch officer and assistant...

法国里昂--(BUSINESS WIRE)--(美国商业资讯)-- Brenus Pharma是一家致力于针对实体瘤开发新型体内免疫疗法的临床阶段生物技术公司。该公司宣布，美国食品药品监督管理局(FDA)已受理其用于治疗微卫星稳定型(MSS)转移性结直肠癌(mCRC)的首款候选药物STC-1010的新药临床试验(IND)申请。 STC-1010旨在解决全球范围内一项极为迫切且尚未满足的医疗需求。在mCRC患者中，约有95%属于MSS肿瘤，这类肿瘤对标准免疫疗法几乎没有应答。此次申请获得FDA受理，印证了Brenus Pharma先进的监管和生产能力。这种运营就绪状态将加速欧洲和美国临床试验中心的患者入组以及数据生成，从而为计划于2027年开展的II期研究项目做好准备。 “FDA此次受理IND申请，是对我们研究项目的一项重大肯定，使我们能够在欧洲和美国全面执行自身临床策略。在多个司法管辖区达成监管共识，反映了我们团队深厚的专业知识，以及本公司致力于将STC-1010带给有需要的患者的坚定承诺。” 首席执行官Paul BRAVETTI表示。 “对于Brenus而言，这是一项令人瞩目的成就，...

フランス・リヨン--(BUSINESS WIRE)--（ビジネスワイヤ） -- 固形がんを対象とした新規の生体内免疫療法を開発する臨床段階のバイオテクノロジー企業であるBrenus Pharmaは、米国食品医薬品局（FDA）が、マイクロサテライト安定型（MSS）転移性大腸がん（mCRC）を対象とした同社初の治験薬候補STC-1010に関する治験薬（IND）申請を受理したと発表しました。 STC-1010は、世界における重要なアンメットニーズに対応するために開発されました。mCRC患者の約95%はMSS腫瘍を有しており、標準的な免疫療法に対する反応はごくわずかです。FDAは、Brenus Pharmaの高度な薬事および製造能力を認めました。この運用体制の整備により、2027年に予定されている第II相プログラムに向けて、欧州および米国の両試験施設における患者アクセスとデータ取得が加速されます。 「FDAによる当社INDの受理は、当社プログラムの大きな裏付けであり、欧州および米国における臨床戦略の本格的な実行を可能にするものです。複数の管轄当局にわたる薬事調整を実現できたことは、当社チーム...